SHG:688105 - Nanjing Vazyme Biotech Co Ltd

Nanjing Vazyme Biotech Co Ltd
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2017 Q4	2018 Q4	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	72.82% -	72.82% 0%	70.81% -2.8%	70.81% 0%	70.81% 0%	74.56% 5.3%	74.56% 0%	71.3% -4.4%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	47.64% -13.4%	44.72% -6.1%	36.3% -18.8%	33.58% -7.5%	33.81% 0.7%	30.43% -10.0%	16.65% -45.3%	3.88% -76.7%	-4% -	-10.87% -	-5.52% -	-1.18% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	88.05% -3.7%	87.5% -0.6%	81.22% -7.2%	75.85% -6.6%	75.18% -0.9%	72.07% -4.1%	68.88% -4.4%	66.88% -2.9%	66.28% -0.9%	65.45% -1.3%	71.03% 8.5%	71.59% 0.8%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	56.86% -18.7%	52.49% -7.7%	42.62% -18.8%	40.15% -5.8%	40% -0.4%	35.59% -11.0%	34.66% -2.6%	23.64% -31.8%	16.62% -29.7%	12.19% -26.7%	-2.98% -	-1.34% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.6B -15.9%	1.71B 7.4%	1.87B 9.0%	2.3B 23.2%	2.66B 15.7%	2.89B 8.3%	3.57B 23.7%	2.9B -18.9%	2.52B -13.0%	2.13B -15.4%	1.29B -39.7%	1.29B 0.0%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.14B 3.4%	2.29B 7.2%	4.61B 101.2%	5.46B 18.5%	5.47B 0.2%	5.89B 7.6%	6.01B 2.0%	6.32B 5.2%	5.76B -8.9%	5.71B -0.8%	5.75B 0.6%	5.41B -5.8%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	407.23M 3.6%	401.48M -1.4%	479.83M 19.5%	898.45M 87.2%	844.05M -6.1%	1.12B 32.5%	1.39B 24.5%	1.77B 26.9%	1.74B -1.6%	1.69B -2.6%	1.72B 1.3%	1.42B -17.5%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.73B 3.4%	1.89B 9.3%	4.13B 118.6%	4.56B 10.5%	4.62B 1.4%	4.76B 3.0%	4.61B -3.2%	4.55B -1.3%	4.02B -11.7%	4.02B 0.0%	4.03B 0.3%	4B -0.8%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	693.23M -	-	616.8M -	-	439.7M -	-	735.17M -	-	648.84M -	-	152.99M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	514.75M 132.3%	90.8M -82.4%	221.6M 144.1%	195.17M -11.9%	250.12M 28.2%	41.35M -83.5%	1.48B 3473.5%	844.29M -42.9%	809.38M -4.1%	953.48M 17.8%	1.34B 41.0%	1.4B 4.4%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	255.93M 31.1%	45.06M -82.4%	1.48B 3179.9%	848.62M -42.6%	810.86M -4.4%	955.64M 17.9%	1.34B 40.7%	1.4B 3.9%	1.76B 25.9%	819.3M -53.4%	848.19M 3.5%	907.81M 7.0%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	463.93M -43.7%	314.58M -32.2%	354.84M 12.8%	-122.89M -	-291.49M -	-366.81M -	-227.69M -	-128M -	126.24M -	151.83M 20.3%	-79.91M -	12.47M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	760.6M -	-	678.29M -	-	900.37M -	-	593.51M -	-	-102.42M -	-	-72.86M -	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.11 -27.3%	2.13 0.9%	1.87 -12.2%	2.02 8.0%	2.31 14.4%	2.21 -4.3%	1.49 -32.6%	0.28 -81.2%	-0.24 -	-0.57 -	-0.18 -	-0.04 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	56.6% -9.5%	40.62% -28.2%	24.85% -38.8%	24.81% -0.1%	28.35% 14.2%	26.4% -6.9%	13.6% -48.5%	2.46% -81.9%	-2.33% -	-5.28% -	-1.64% -	-0.35% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	44.86% -11.3%	33.49% -25.3%	21.81% -34.9%	20.55% -5.8%	23.68% 15.2%	21.48% -9.3%	11.2% -47.9%	1.91% -83.0%	-1.8% -	-4% -	-1.21% -	-0.26% -